Literature DB >> 34192620

It takes two to dance the VBHC tango: A multiple case study of the adoption of value-based strategies in Sweden and Brazil.

Pedro Ramos1, Carl Savage2, Johan Thor2, Rifat Atun3, Karin Solberg Carlsson2, Marcia Makdisse4, Miguel Cendoroglo Neto4, Sidney Klajner4, Paolo Parini5, Pamela Mazzocato2.   

Abstract

Although Value-Based Health Care (VBHC) is widely debated and cited, there are few empirical studies focused on how its concepts are understood and applied in real-world contexts. This comparative case study of two prominent adopters in Brazil and Sweden, situated at either end of the spectrum in terms of contextual prerequisites, provides insights into the complex interactions involved in the adoption of value-based strategies. We found that the adoption of VBHC emphasized either health outcomes or costs - not both as suggested by the value equation. This may be linked to broader health system and societal contexts. Implementation can generate tensions with traditional business models, suggesting that providers should first analyze how these strategies align with their internal context. Adoption by a single provider organization is challenging, if not impossible. An effective VBHC transformation seems to require a systematic and systemic approach where all stakeholders need to clearly define the purpose and the scope of the transformation, and together steer their actions and decisions accordingly.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Keywords:  Brazil; Complex innovation; Organizational research; Sweden; VBHC; Value-based healthcare

Year:  2021        PMID: 34192620     DOI: 10.1016/j.socscimed.2021.114145

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  1 in total

1.  Value-based healthcare in Latin America: a survey of 70 healthcare provider organisations from Argentina, Brazil, Chile, Colombia and Mexico.

Authors:  Marcia Makdisse; Pedro Ramos; Daniel Malheiro; Marcelo Katz; Luisa Novoa; Miguel Cendoroglo Neto; Jose Henrique Germann Ferreira; Sidney Klajner
Journal:  BMJ Open       Date:  2022-06-06       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.